Association between metabolic syndrome and gallstones

Zhou BingBing; Wang XueMei; Zhang Qian; Xu ShiYi; Dan ZhongYan; Lai YaXin; Wang HaoYu

doi:10.3969/j.issn.1001-5256.2017.05.017

Issue 5

May 2017

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2017 > 33(5): 880-882

PDF( 1528 KB)

Association between metabolic syndrome and gallstones

DOI: 10.3969/j.issn.1001-5256.2017.05.017

Department of Ultrasound, The First Affiliated Hospital of China Medical University

Research funding:

Published Date: 2017-05-20

Abstract

Abstract

Objective To investigate the association of metabolic syndrome and its components with gallstones and the factors for the development of gallstones.Methods A total of 445 community residents, who were followed up by Department of Endocrinology in The First Affiliated Hospital of China Medical University from January to June, 2015, were enrolled as study subjects and were divided into metabolic syndrome group with 220 patients and non-metabolic syndrome group with 225 patients.A questionnaire survey, physical examination, and blood test were performed for these patients to obtain the data on sex, age, body height, body weight, waist circumference, blood pressure, and blood biochemical parameters[fasting blood glucose, triglyceride (TG) , and high-density lipoprotein (HDL) ].The chi-square test was used for comparison of categorical data between two groups, the t-test was used for comparison of continuous data between groups, and a multivariate logistic regression analysis was used to identify independent risk factors for the development of gallstones.Results Of all patients, 49 (11.01%) had gallstones, among whom 38 (17.27%) were in the metabolic syndrome group and 11 (4.89%) were in the non-metabolic syndrome group;the metabolic syndrome group had a significant increase in the prevalence rate of gallstones (χ2=17.409, P<0.001) .The multivariate logistic regression analysis showed that increased waist circumference (OR=1.088, P<0.001) , increased TG level (OR=1.209, P=0.038) , and reduced HDL level (OR=0.329, P=0.014) were independent risk factors for gallstones.Conclusion Increased waist circumference, increased TG level, and reduced HDL level may be independent risk factors for the development of gallstones.
- metabolic syndrome X,
- cholecystolithiasis,
- risk factors

FullText(HTML)

References(15)

References

[1]LIM SH, KIM DH, PARK MJ, et al.Is metabolic syndrome one of the risk factors for gallbladder polyps found by ultrasonography during health screening?[J].Gut Liver, 2007, 1 (2) :138-144.

[2]LUO YY, JI LN.The role of genetics metabolic syndrome[J].Med Philosophy, 2009, 30 (1) :18-20. (in Chinese) 罗樱樱, 纪立农.代谢综合征与遗传[J].医学与哲学, 2009, 30 (1) :18-20.

[3]ALBERTI KG, EOKEL RH, GRUNDY SM, et al.Harmonizing the metabolic syndrome;a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and revention;National Heart, Lung, and Blood Institute;American Heart Association;Word Heart Federation;International A[J].Circulation, 2010, 120 (16) :1640.

[4]BODMER M, BRAUCHLI YB, KRAHENBUHL S, et al.Statin use and risk of gallstone disease followed by cholecystecomy[J].JAMA, 2009, 302 (18) :2001-2007.

[5]LI J, WEI XG, LU QM, et al.Research advances in association between diseases outside the gallbladder and gallstones[J].J Clin Hepatol, 2016, 32 (5) :1018-1021. (in Chinese) 李娟, 魏小果, 卢启明, 等.胆外疾病与胆囊结石相关性的研究进展[J].临床肝胆病杂志, 2016, 32 (5) :1018-1021.

[6]CHEN LY, QIAO QH, ZHANG SC, et al.Metabolic syndrome and gallstone disease[J].World J Gastroenterol, 2012, 18 (31) :4215-4220.

[7]ZHANG G, NI YX, ZHAO ZG, et al.Evaluation of target organ damage using different diagnostic criteria for metabolic syndrome in diabetes mellitus and hypertension patients[J].Chin J Geriatr Heart Brain Ves Dis, 2005, 7 (6) :363-366. (in Chinese) 张刚, 倪银星, 赵志钢, 等.不同代谢综合征诊断标准对靶器官损害的检出[J].中华老年心脑血管病杂志, 2005, 7 (6) :363-366.

[8]DANNDONA P, ALJADA A, CHAUDHURI A, et al.Metabolic syndrome:a comprehensive perspective based on intemctions between obesity, diabetes, and inflammation[J].Circulation, 2005, 111 (11) :1448-1454.

[9]LI T, LOU PA, CHEN PP, et al.A cross sectional study on the predictive value of body mass index and waist circumference for the risk of hypertension and diabetes of the residents in Xuzhou City[J].Chin J Endocrinol Met, 2016, 32 (10) :803-807. (in Chinese) 李婷, 娄培安, 陈培培, 等.体重指数与腰围预测徐州市居民罹患高血压、糖尿病风险的横断面研究[J].中华内分泌代谢杂志, 2016, 32 (10) :803-807.

[10]LI X, ZHAO WZ, LIU BH, et al.Risk factors of cholelithiasis in Baotou, Inner Mongolia population:a case-control study[J/CD].Chin J Clinicians:Electronic Edition, 2014, 8 (24) :4410-4417. (in Chinese) 李霞, 赵文芝, 刘宝花, 等.内蒙古包头地区胆石症危险因素的研究[J/CD].中华临床医师杂志:电子版, 2014, 8 (24) :4410-4417.

[11]ZHANG J, LIU J, CHEN D, et al.Correlation of gallstone with metabolic syndrome and its components in physical examination population in Xinjiang[J].J Chin Pract Diagn Ther, 2016, 30 (9) :894-896. (in Chinese) 张静, 刘静, 陈丹, 等.新疆地区体检人群胆囊结石与代谢综合征及其组分相关性分析[J].中华实用诊断与治疗杂志, 2016, 30 (9) :894-896.

[12]CHEN Y, KONG J, WU S.Cholesterol gallstone disease:focusing on the role of gallbladder[J].Lab Invest, 2015, 95 (2) :124-131.

[13]LEVINSON SS.High-density lipoprotein metabolism and reverse cholesterol transport[J].J Clin Lig Ass, 2006, 29 (1) :23-28.

[14]CHEN JH, QIAO QH, ZHU WH, et al.Association between metabolic syndrome and gallstone disease[J].Clin Educ Gen Pract, 2015, 11 (13) :632-634. (in Chinese) 陈建华, 乔巧华, 朱文华, 等.代谢综合征与胆囊结石的相关性研究[J].全科医学临床与教育杂志, 2015, 11 (13) :632-634.

[15]YANG ZZ, LIU DM, XIAO WD, et al.Analysis of sex difference in prevalence of gallstone[J].Mod J Int Trad Chin West Med, 2014, 23 (18) :1981-1983. (in Chinese) 杨真真, 刘大毛, 肖卫东, 等.胆囊结石患病率的性别差异分析[J].现代中西医结合杂志, 2014, 23 (18) :1981-1983.

Relative Articles

[1]	Jiqiang LI, Guixin ZHANG. Research advances in the risk factors for recurrence of common bile duct stone after choledocholithotomy[J]. Journal of Clinical Hepatology, 2023, 39(1): 231-237. doi: 10.3969/j.issn.1001-5256.2023.01.036
[2]	Xiaoyong DUO, Shijie ZHANG, Hongwei ZHANG, Jing YANG, Wenqiang WANG, Linzhi YU, Baocai ZHANG, Yicheng ZHUO, Yunchao JIA, Yan PENG, Shuai HU. Association between gallstones and metabolic syndrome in southern Xinjiang, China[J]. Journal of Clinical Hepatology, 2022, 38(8): 1859-1864. doi: 10.3969/j.issn.1001-5256.2022.08.026
[3]	Dongxu WANG, Chuan XING, Bo LYU, Han ZHAO, Bing HE. Risk factors for polycystic ovary syndrome with nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2021, 37(10): 2474-2477. doi: 10.3969/j.issn.1001-5256.2021.10.046
[4]	Zhang Chi, Hu ShuLing, Sun Peng, Bai Ye, Wang YuTong, Zhang Ben, Gu DongQing, Wang Xin. Prevalence of gallstones among university teachers and related risk factors: A multicenter study[J]. Journal of Clinical Hepatology, 2020, 36(3): 624-630. doi: 10.3969/j.issn.1001-5256.2020.03.031
[5]	LI ZhengHong, DONG YuWei, LU LunGen. Risk factors,diagnosis,and updated classification of hepatorenal syndrome[J]. Journal of Clinical Hepatology, 2020, 36(11): 2411-2414. doi: 10.3969/j.issn.1001-5256.2020.11.003
[6]	Yao ChengZi, Feng Gong, Yu WenSi, Du Huan, Mi Man. Risk factors for the development and progression of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2020, 36(2): 433-436. doi: 10.3969/j.issn.1001-5256.2020.02.044
[7]	Tian Tian, Hu WenWei, Li Xue, Li Ji, Zhang Dan, Li ZhangZheng. Metabolic characteristics of nonalcoholic fatty liver disease and related risk factors in non-obese population[J]. Journal of Clinical Hepatology, 2020, 36(6): 1310-1313. doi: 10.3969/j.issn.1001-5256.2020.06.024
[8]	Bai JiDong, Xue RongQuan, Bai YongLe, Xia YiJun, Wang XiDong, Xi LongFu, Han XiaoYue, Han LiBo. Association between metabolic syndrome and gallstones[J]. Journal of Clinical Hepatology, 2020, 36(3): 701-703. doi: 10.3969/j.issn.1001-5256.2020.03.052
[9]	Chen ShanPeng, Wang ZhiXiang, Zhang XiaoDi, Shen NaiYing, Wei ZhiLi. Epidemiology of polypoid lesions of the gallbladder and related risk factors[J]. Journal of Clinical Hepatology, 2019, 35(2): 441-443. doi: 10.3969/j.issn.1001-5256.2019.02.045
[10]	Wang XianPeng, Meng XianZhi. Risk factors for gallstones complicated by acute biliary pancreatitis[J]. Journal of Clinical Hepatology, 2018, 34(8): 1728-1732. doi: 10.3969/j.issn.1001-5256.2018.08.027
[11]	Yang Bo, Hou YongZhi, Wang XiangFei, De Ji, Bin YeJian, Bai Zhen, Mi Ma. Risk factors for gallstones in Tibetan Plateau[J]. Journal of Clinical Hepatology, 2018, 34(4): 789-794. doi: 10.3969/j.issn.1001-5256.2018.04.019
[12]	Wang ChunQiu, Ma YingCai, Zhu ZhiYong, Yuan Ling. Risk factors for recurrence of common bile duct stones after endoscopic retrograde cholangiopancreatography[J]. Journal of Clinical Hepatology, 2017, 33(2): 297-299. doi: 10.3969/j.issn.1001-5256.2017.02.019
[13]	Qian Rui, Chen XiaoPeng. Risk factors for recurrence after surgery for common bile duct stones[J]. Journal of Clinical Hepatology, 2017, 33(2): 394-399. doi: 10.3969/j.issn.1001-5256.2017.02.042
[14]	Liu Pei, Gao ShiCheng. Risk factors for liver injury in patients with acquired immunodeficiency syndrome treated with nevirapine[J]. Journal of Clinical Hepatology, 2016, 32(7): 1373-1377. doi: 10.3969/j.issn.1001-5256.2016.07.035
[15]	Zhu Ying, Wu ZhiYu, Ma XiangMing, Dong Hao, Qu ShunXi, Tian Yuan, Li ZhenHua, Cao LiYing, Fu QingJiang. An epidemiological investigation of cholelithiasis in employees of Kailuan Corporation in Tangshan of Hebei Province, China[J]. Journal of Clinical Hepatology, 2015, 31(10): 1621-1624. doi: 10.3969/j.issn.1001-5256.2015.10.015
[16]	Fan JianGao, Zhu ChanYan. Strengthening research on relationship between metabolic syndrome and chronic liver disease[J]. Journal of Clinical Hepatology, 2013, 29(12): 881-884. doi: 10.3969/j.issn.1001-5256.2013.12.001
[17]	Chen YongFang, Wu ZhanJun. Pathogenesis and risk factors of cholesterol gallstones in patients with non- alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2013, 29(12): 952-955. doi: 10.3969/j.issn.1001-5256.2013.12.021
[18]	Lu: RiYing, Wu JiZhou. Risk factors of hepatorenal syndrome in patients with severe hepatitis[J]. Journal of Clinical Hepatology, 2012, 28(7): 542-544.
[19]	Ruan JianWen, Yang Jing, Gao LiJuan. Advances in the relationship between metabolic syndrome and nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2011, 27(10): 1102-1105.
[20]	Wu Tao, Yin ShouYi, Wang HongZhang, Zhang Hong, Jia Wei, Ji Guang. The clinical features and risk factors of patient with metabolic syndrome combined with non-alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2011, 27(10): 1036-1040.

Supplements(0)

Cited By

Cited by

Periodical cited type(15)

1.	吴丽丽，张言涛. 围绝经期女性胆囊炎发生情况及与血脂和内分泌代谢的关系. 中国妇幼保健. 2024(03): 547-550 .
2.	董碧菁，王莉，陈雨静. 围绝经期女性胆囊结石检出情况及与内分泌和血脂代谢的相关性分析. 中国妇幼保健. 2024(09): 1714-1717 .
3.	谢毅，陈森林，于菲菲. 特高海拔地区基层医院援藏手术医师在不同给氧条件下开展小切口胆囊切除术的效果评价. 中华航海医学与高气压医学杂志. 2024(04): 509-512 .
4.	郑莉艳，姚丽，孔冬梅. 围绝经期综合征女性胆囊胆固醇结石形成的影响因素. 中国妇幼保健. 2024(22): 4554-4557 .
5.	郭志斌，张文兴. 蒿芩清胆汤联合耳穴压豆治疗肝胆湿热型胆囊结石疗效观察. 广西中医药. 2022(03): 1-4 .
6.	向云，易华清，金剑. 胆囊结石腹腔镜手术患者术后生活质量的影响因素及干预措施分析. 吉林医学. 2022(09): 2469-2471 .
7.	张培松，何新苗，龚义飞，曹葆强. 妊娠期合并胆囊结石的影响因素分析. 中华灾害救援医学. 2021(01): 768-770 .
8.	章俊芹，裴仁明，马娜. MRCP对胆囊结石的诊断及应用价值分析. 湖南师范大学学报(医学版). 2020(02): 96-98 .
9.	周洋，卓臣义，唐乾利. 胆囊结石形成机制及诊疗现状研究. 右江民族医学院学报. 2019(02): 203-206 .
10.	程首仁. 胆囊结石患者腹腔镜下胆囊切除术围术期血清胆红素水平和创伤应激指标变化分析. 中外医学研究. 2019(26): 17-19 .
11.	王芃，张林波，黄萍，黄春霞，陆志杰. 常规体检者胆囊结石的检出情况及其影响因素分析. 广西医学. 2018(14): 1595-1598 .
12.	杨波，侯永志，王翔飞，德吉，宾业健，白珍，米玛. 西藏高原地区胆囊结石危险因素分析. 临床肝胆病杂志. 2018(04): 789-794 . 本站查看
13.	刘志渊. 胆宁片预防完全腹腔保胆取石术后胆囊结石复发的效果观察. 内蒙古医学杂志. 2018(02): 220-221 .
14.	徐乾坤，曾凡超，林军，郑攀丰，张志炎. 试析泌尿系结石病患者中代谢综合征与结石复发的关联. 中国社区医师. 2018(14): 64-65 .
15.	杜前程，周瀛，张灵强，胡陈亮，樊海宁. 结石性胆囊炎的个体化治疗. 临床肝胆病杂志. 2018(10): 2251-2256 . 本站查看

Other cited types(11)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (2734) PDF downloads(456)

Association between metabolic syndrome and gallstones

DOI: 10.3969/j.issn.1001-5256.2017.05.017